These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 29857020)
1. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma. Yang S; Jia R; Bian Z Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020 [TBL] [Abstract][Full Text] [Related]
2. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells. Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105 [TBL] [Abstract][Full Text] [Related]
3. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells. Guo J; Jia J; Jia R Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554 [TBL] [Abstract][Full Text] [Related]
4. Expression of SRSF3 is Correlated with Carcinogenesis and Progression of Oral Squamous Cell Carcinoma. Peiqi L; Zhaozhong G; Yaotian Y; Jun J; Jihua G; Rong J Int J Med Sci; 2016; 13(7):533-9. PubMed ID: 27429590 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment. Sun Y; Yan L; Guo J; Shao J; Jia R Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668 [TBL] [Abstract][Full Text] [Related]
6. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma. Xu L; Shen J; Jia J; Jia R Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152 [TBL] [Abstract][Full Text] [Related]
7. Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer. Sharma S; Mittal M; Shukla A; Khan J; Dinand V; Saluja D BMC Cancer; 2024 Sep; 24(1):1094. PubMed ID: 39227899 [TBL] [Abstract][Full Text] [Related]
8. Oncogene SRSF3 suppresses autophagy via inhibiting BECN1 expression. Zhou L; Guo J; Jia R Biochem Biophys Res Commun; 2019 Feb; 509(4):966-972. PubMed ID: 30654935 [TBL] [Abstract][Full Text] [Related]
9. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell. Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007 [TBL] [Abstract][Full Text] [Related]
10. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes. Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3. Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456 [TBL] [Abstract][Full Text] [Related]
12. Proteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5 mRNA upregulation during late erythroid differentiation. Breig O; Baklouti F PLoS One; 2013; 8(3):e59137. PubMed ID: 23536862 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells. Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797 [TBL] [Abstract][Full Text] [Related]
14. Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis. More DA; Singh N; Mishra R; Muralidharan HP; Gopinath KS; Gopal C; Kumar A PLoS One; 2024; 19(5):e0296565. PubMed ID: 38781195 [TBL] [Abstract][Full Text] [Related]
15. SRSF3 suppresses RCC tumorigenesis and progression via regulating SP4 alternative splicing. Zhang L; Zhang H; Tang Y; Dai C; Zheng J Biochim Biophys Acta Mol Cell Res; 2024 Dec; 1871(8):119841. PubMed ID: 39222664 [TBL] [Abstract][Full Text] [Related]
16. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2. DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells. Yan J; Zhang D; Han Y; Wang Z; Ma C J Cell Biochem; 2019 Oct; 120(10):17303-17311. PubMed ID: 31106485 [TBL] [Abstract][Full Text] [Related]
18. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair. He X; Zhang P Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282 [TBL] [Abstract][Full Text] [Related]
19. A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells. Ajiro M; Jia R; Yang Y; Zhu J; Zheng ZM Nucleic Acids Res; 2016 Feb; 44(4):1854-70. PubMed ID: 26704980 [TBL] [Abstract][Full Text] [Related]
20. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer. Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]